Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kristina Masson Insider Profile
4 Followers
Kristina Masson, EVP - Business Operations, Director at Acrivon Therapeutics, Inc., holds 2.88M shares in Acrivon Therapeutics, Inc. (Ticker: ACRV).
Kristina Masson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kristina Masson's holdings
Insider Roles
EVP - Business Operations, Director
Roles that Kristina Masson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kristina Masson
Kristina Masson's Trading History
List of latest transactions for each holding click on a transaction to see Kristina Masson's performance on stock
You May Also Like
Kristina Masson insider profile FAQ
What is the percentage of profitable transactions made by Kristina Masson?
The percentage of profitable transactions made by Kristina Masson is ―.
What is the average return per transaction made by Kristina Masson?
The average return per transaction made by Kristina Masson is ―.
What stocks does Kristina Masson hold?
Kristina Masson holds: ACRV stocks.
What was Kristina Masson’s latest transaction?
Kristina Masson latest transaction was an Uninformative Sell of $4.10K.
What was Kristina Masson's most profitable transaction?
Kristina Masson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kristina Masson's role in Acrivon Therapeutics, Inc.?
Kristina Masson's role in Acrivon Therapeutics, Inc. is EVP - Business Operations, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.